Assam Government TenderExpired

Essential Drugs under SDL

Issued by: Health and Family Welfare Department
Location: AMSCL

Tender Description

Supply of essential drugs under SDL.

Assam Government Tender○ Closed
Ref. NoESSENTIAL DRUGS UNDER SDL 7-01-2026
Est. Value₹55.94 Cr
Deadline11-Feb-2026 02:00 PM
TypeOpen Tender
AMSCL
Published 08-Jan-2026 10:30 AM

Tender Specifications & Timeline

16 Fields
Estimated Value
₹55.94 Cr
Organisation
Health and Family Welfare Department
Reference No.
ESSENTIAL DRUGS UNDER SDL 7-01-2026
Status
Expired
Location
AMSCL
Source
Assam eProcurement
Tender Type
Open Tender
Tender Category
Goods
Status Stage
Financial Evaluation
Published Date
08-Jan-2026 10:30 AM
Submission Deadline
11-Feb-2026 02:00 PM
Submission Start
26-Jan-2026 02:00 PM
Bid Opening Date
11-Feb-2026 04:00 PM
Bid Opening Place
AMSCL
Pre-Bid Meeting
12-Jan-2026 11:30 AM
Period of Work
60 Days
L1 Bidder & Competitor IntelligenceFinancial Evaluation

Total Bidders

46

Lowest Bid (L1)

₹1

Estimated Value (PAC)

₹55.94 Cr

Margin vs Estimate

—

Lowest Bidder (L1) · Award pending

Accepted-Finance

L1 to L2 Spread

+0.00%

Completion Period

60 days

RankBidder / ContractorQuoted BidGap vs L1vs EstimateStatus
L1₹10.0% (L1)—Accepted-Finance
L1₹10.0% (L1)—Accepted-Finance
L1₹10.0% (L1)—Accepted-Finance
L1₹10.0% (L1)—Accepted-Finance
L1₹10.0% (L1)—Accepted-Finance
L1₹10.0% (L1)—Accepted-Finance
L1₹10.0% (L1)—Accepted-Finance
L1₹10.0% (L1)—Accepted-Finance
L1₹10.0% (L1)—Accepted-Finance
L1₹10.0% (L1)—Accepted-Finance
L1₹10.0% (L1)—Accepted-Finance
L1₹10.0% (L1)—Accepted-Finance
L1₹10.0% (L1)—Accepted-Finance
L1₹10.0% (L1)—Accepted-Finance
L1₹10.0% (L1)—Accepted-Finance
L1₹10.0% (L1)—Accepted-Finance
L1₹10.0% (L1)—Accepted-Finance
L1₹10.0% (L1)—Accepted-Finance
L1₹10.0% (L1)—Accepted-Finance
L1₹10.0% (L1)—Accepted-Finance
L1₹10.0% (L1)—Accepted-Finance
L1₹10.0% (L1)—Accepted-Finance
L1₹10.0% (L1)—Accepted-Finance
L1₹10.0% (L1)—Accepted-Finance
L1₹10.0% (L1)—Accepted-Finance
L1₹10.0% (L1)—Accepted-Finance
L1₹10.0% (L1)—Accepted-Finance
L1₹10.0% (L1)—Accepted-Finance
L1₹10.0% (L1)—Accepted-Finance
L1₹10.0% (L1)—Accepted-Finance
L1₹10.0% (L1)—Accepted-Finance
L1₹10.0% (L1)—Accepted-Finance
L1₹10.0% (L1)—Accepted-Finance
NO₹2+100.00%Rejected-FinRejected-Finance
NO₹2+100.00%Rejected-FinRejected-Finance
NO₹2+100.00%Rejected-FinRejected-Finance
NO₹2+100.00%Rejected-FinRejected-Finance
NO₹2+100.00%Rejected-FinRejected-Finance
NO₹2+100.00%Rejected-FinRejected-Finance
NO₹2+100.00%Rejected-FinRejected-Finance
NO₹2+100.00%Rejected-FinRejected-Finance
NO₹2+100.00%Rejected-FinRejected-Finance
NO₹2+100.00%Rejected-FinRejected-Finance
DQ——Rejected-TechRejected-Technical
DQ——Rejected-TechRejected-Technical
DQ——Rejected-TechRejected-Technical

This tender covers essential Drugs under SDL, issued by Health and Family Welfare Department under reference ESSENTIAL DRUGS UNDER SDL 7-01-2026. The estimated contract value is ₹55.94 Cr, and the tender is currently Expired. Under financial bid evaluation, ADMAC LIFESCIENCES emerged as the lowest (L1) bidder with a quoted bid amount of ₹1.

This procurement is part of ongoing efforts by central government agencies and public sector undertakings to maintain and upgrade public infrastructure and services in AMSCL. Vendors interested in similar opportunities can browse other tenders from the same issuing organisation below.

Submitted Bids & Bidder Details
ADMAC LIFESCIENCES
#297227
Accepted-Finance
Submitted: 11-Feb-2026 12:59 PM
Fin. Value: 1.00
Rank: L1
Updated: 17-Jul-2026 05:36 PM

As per minutes

ASTRAZENECA PHARMA INDIA LIMITED
#296280
Accepted-Finance
Submitted: 02-Feb-2026 05:50 PM
Fin. Value: 1.00
Rank: L1
Updated: 17-Jul-2026 05:36 PM

As per minutes

Bajaj Healthcare Ltd
#295936
Accepted-Finance
Submitted: 07-Feb-2026 02:49 PM
Fin. Value: 1.00
Rank: L1
Updated: 17-Jul-2026 05:36 PM

As per minutes

BHARAT SERUMS AND VACCINES LIMITED
#296294
Accepted-Finance
Submitted: 06-Feb-2026 10:30 AM
Fin. Value: 1.00
Rank: L1
Updated: 17-Jul-2026 05:36 PM

As per minutes

Biodeal Pharmaceuticals Limited
#296348
Rejected-Finance
Submitted: 10-Feb-2026 04:22 PM
Fin. Value: 2.00
Rank: No
Updated: 17-Jul-2026 05:36 PM

As per minutes

Bristol Myers Squibb India Pvt Ltd
#295092
Accepted-Finance
Submitted: 05-Feb-2026 06:58 PM
Fin. Value: 1.00
Rank: L1
Updated: 17-Jul-2026 05:36 PM

As per minutes

CMG BIOTECH PVT. LTD.
#296156
Accepted-Finance
Submitted: 11-Feb-2026 01:41 PM
Fin. Value: 1.00
Rank: L1
Updated: 17-Jul-2026 05:36 PM

As per minutes

CONCORD BIOTECH LIMITED
#295126
Rejected-Finance
Submitted: 09-Feb-2026 12:05 PM
Fin. Value: 2.00
Rank: No
Updated: 17-Jul-2026 05:36 PM

As per minutes

Dr Reddys Laboratories Limited
#297140
Accepted-Finance
Submitted: 11-Feb-2026 01:10 PM
Fin. Value: 1.00
Rank: L1
Updated: 17-Jul-2026 05:36 PM

As per minutes

EISAI PHARMACEUTICALS INDIA PVT. LTD
#296288
Rejected-Finance
Submitted: 10-Feb-2026 03:17 PM
Fin. Value: 2.00
Rank: No
Updated: 17-Jul-2026 05:36 PM

As per minutes

Ferring Pharmaceuticals Pvt Ltd
#296573
Accepted-Finance
Submitted: 05-Feb-2026 07:44 PM
Fin. Value: 1.00
Rank: L1
Updated: 17-Jul-2026 05:36 PM

As per minutes

Fresenius Kabi india Pvt Ltd
#296432
Accepted-Finance
Submitted: 09-Feb-2026 08:19 PM
Fin. Value: 1.00
Rank: L1
Updated: 17-Jul-2026 05:36 PM

As per minutes

Getwell Pharmaceuticals
#296607
Accepted-Finance
Submitted: 11-Feb-2026 12:31 PM
Fin. Value: 1.00
Rank: L1
Updated: 17-Jul-2026 05:36 PM

As per minutes

GlaxoSmithKline Pharmaceuticals Limited
#295203
Accepted-Finance
Submitted: 02-Feb-2026 04:18 PM
Fin. Value: 1.00
Rank: L1
Updated: 17-Jul-2026 05:36 PM

As per minutes

GLS PHARMA LTD.
#295090
Rejected-Technical
Submitted: 11-Feb-2026 12:11 PM
Fin. Value: —
Rank: —
Updated: 02-Mar-2026 01:31 PM

As per minutes

Grifols India Healthcare Private Limited
#295891
Rejected-Finance
Submitted: 11-Feb-2026 11:13 AM
Fin. Value: 2.00
Rank: No
Updated: 17-Jul-2026 05:36 PM

As per minutes

HEALTH BIOTECH LIMITED
#297296
Accepted-Finance
Submitted: 11-Feb-2026 12:29 PM
Fin. Value: 1.00
Rank: L1
Updated: 17-Jul-2026 05:36 PM

As per minutes

Hetero Healthcare Ltd
#297135
Accepted-Finance
Submitted: 11-Feb-2026 01:31 PM
Fin. Value: 1.00
Rank: L1
Updated: 17-Jul-2026 05:36 PM

As per minutes

INTAS PHARMACEUTICALS LIMITED
#296616
Accepted-Finance
Submitted: 10-Feb-2026 04:43 PM
Fin. Value: 1.00
Rank: L1
Updated: 17-Jul-2026 05:36 PM

As per minutes

J DUNCAN HEALTHCARE PVT LTD
#295926
Accepted-Finance
Submitted: 04-Feb-2026 04:28 PM
Fin. Value: 1.00
Rank: L1
Updated: 17-Jul-2026 05:36 PM

As per minutes

JODAS EXPOIM PVT LTD
#297315
Rejected-Finance
Submitted: 11-Feb-2026 12:23 PM
Fin. Value: 2.00
Rank: No
Updated: 17-Jul-2026 05:36 PM

As per minutes

Johnson and Johnson Private Limited
#296671
Accepted-Finance
Submitted: 11-Feb-2026 10:23 AM
Fin. Value: 1.00
Rank: L1
Updated: 17-Jul-2026 05:36 PM

As per minutes

KHANDELWAL LABORATORIES PVT LTD
#295443
Accepted-Finance
Submitted: 10-Feb-2026 04:55 PM
Fin. Value: 1.00
Rank: L1
Updated: 17-Jul-2026 05:36 PM

As per minutes

Lupin Limited
#295747
Accepted-Finance
Submitted: 11-Feb-2026 11:10 AM
Fin. Value: 1.00
Rank: L1
Updated: 17-Jul-2026 05:36 PM

As per minutes

Macleods Pharmaceuticals Limited
#295984
Rejected-Finance
Submitted: 10-Feb-2026 03:41 PM
Fin. Value: 2.00
Rank: No
Updated: 17-Jul-2026 05:36 PM

As per minutes

MSD PHARMACEUTICALS PRIVATE LIMITED
#295119
Rejected-Technical
Submitted: 06-Feb-2026 11:19 AM
Fin. Value: —
Rank: —
Updated: 02-Mar-2026 01:31 PM

As per Minutes

MSN Laboratories Private Limited
#296154
Accepted-Finance
Submitted: 11-Feb-2026 01:14 PM
Fin. Value: 1.00
Rank: L1
Updated: 17-Jul-2026 05:36 PM

As per minutes

M/s. Pfizer Products India Private Limited
#296486
Accepted-Finance
Submitted: 10-Feb-2026 04:50 PM
Fin. Value: 1.00
Rank: L1
Updated: 17-Jul-2026 05:36 PM

As per minutes

Naprod Lifesciences pvt. ltd.
#295999
Rejected-Finance
Submitted: 11-Feb-2026 12:18 PM
Fin. Value: 2.00
Rank: No
Updated: 17-Jul-2026 05:36 PM

As per minutes

NIXI LABORATORIES PVT LTD
#296646
Accepted-Finance
Submitted: 10-Feb-2026 05:32 PM
Fin. Value: 1.00
Rank: L1
Updated: 17-Jul-2026 05:36 PM

As per minutes

novartis healthcare pvt ltd
#295075
Accepted-Finance
Submitted: 10-Feb-2026 02:55 PM
Fin. Value: 1.00
Rank: L1
Updated: 17-Jul-2026 05:36 PM

As per minutes

Novo Nordisk India Private Limited
#295998
Accepted-Finance
Submitted: 09-Feb-2026 02:56 PM
Fin. Value: 1.00
Rank: L1
Updated: 17-Jul-2026 05:36 PM

As per minutes

RELIANCE LIFE SCIENCES PRIVATE LIMITED
#296584
Accepted-Finance
Submitted: 11-Feb-2026 11:56 AM
Fin. Value: 1.00
Rank: L1
Updated: 17-Jul-2026 05:36 PM

As per minutes

RIVPRA FORMULATION PVT LTD
#297061
Accepted-Finance
Submitted: 11-Feb-2026 10:46 AM
Fin. Value: 1.00
Rank: L1
Updated: 17-Jul-2026 05:36 PM

As per minutes

Roche Products (India) Pvt Ltd
#295171
Accepted-Finance
Submitted: 10-Feb-2026 02:05 PM
Fin. Value: 1.00
Rank: L1
Updated: 17-Jul-2026 05:36 PM

As per minutes

Samarth Life Science Pvt. Ltd
#297058
Rejected-Technical
Submitted: 10-Feb-2026 05:02 PM
Fin. Value: —
Rank: —
Updated: 02-Mar-2026 01:31 PM

As per minutes

Shilpa Medicare Limited
#297184
Accepted-Finance
Submitted: 11-Feb-2026 10:06 AM
Fin. Value: 1.00
Rank: L1
Updated: 17-Jul-2026 05:36 PM

As per minutes

Sun Pharmaceutical Industries Ltd
#295071
Accepted-Finance
Submitted: 09-Feb-2026 04:03 PM
Fin. Value: 1.00
Rank: L1
Updated: 17-Jul-2026 05:36 PM

As per minutes

SUPERMAX DRUGS & PHARMACEUTICALS PVT LTD
#297053
Accepted-Finance
Submitted: 11-Feb-2026 11:37 AM
Fin. Value: 1.00
Rank: L1
Updated: 17-Jul-2026 05:36 PM

As per minutes

Takeda Biopharmaceuticals India Private Limited
#295435
Accepted-Finance
Submitted: 04-Feb-2026 02:42 PM
Fin. Value: 1.00
Rank: L1
Updated: 17-Jul-2026 05:36 PM

As per minutes

ULTRA DRUGS PRIVATE LIMITED
#295729
Accepted-Finance
Submitted: 09-Feb-2026 04:59 PM
Fin. Value: 1.00
Rank: L1
Updated: 17-Jul-2026 05:36 PM

As per minutes

UNICURE INDIA LTD
#297106
Accepted-Finance
Submitted: 11-Feb-2026 09:41 AM
Fin. Value: 1.00
Rank: L1
Updated: 17-Jul-2026 05:36 PM

As per minutes

UNITED BIOTECH PVT.LTD.
#295474
Rejected-Finance
Submitted: 05-Feb-2026 03:38 PM
Fin. Value: 2.00
Rank: No
Updated: 17-Jul-2026 05:36 PM

As per minutes

VENUS REMEDIES LIMITED
#295766
Rejected-Finance
Submitted: 04-Feb-2026 03:26 PM
Fin. Value: 2.00
Rank: No
Updated: 17-Jul-2026 05:36 PM

As per minutes

VERVE HUMAN CARE LABORATORIES
#295124
Accepted-Finance
Submitted: 10-Feb-2026 05:42 PM
Fin. Value: 1.00
Rank: L1
Updated: 17-Jul-2026 05:36 PM

As per minutes

ZYDUS LIFESCIENCES LIMITED
#296575
Rejected-Finance
Submitted: 06-Feb-2026 11:38 AM
Fin. Value: 2.00
Rank: No
Updated: 17-Jul-2026 05:36 PM

As per minutes

Bid Evaluation Details & Logs

Technical

technical bid opening

Date: 02-Mar-2026 11:47 AM

Officer: Siddhartha Bahadur Singh

Opened

technical evaluation

technical evaluation

Date: 02-Mar-2026 01:31 PM

Officer: Siddhartha Bahadur Singh

Finance

finance bid opening

Date: 13-Mar-2026 12:53 PM

Officer: Medini Mohan Saikia

opened

finance evaluation

finance evaluation

Date: 17-Jul-2026 05:36 PM

Officer: Medini Mohan Saikia

About This Procurement Notice

This Assam state government tender was issued by Health and Family Welfare Department. The estimated contract value is ₹55.94 Cr. Bids must be submitted by 11-Feb-2026 02:00 PM.

BiharInfraTales aggregates procurement notices from Bihar eProcurement, GeM portal, and central government tender portals. Data is refreshed every 30 minutes. Always verify details on the official portal before submitting a bid.

?

Frequently Asked Questions

QWhat is the status of the tender "Essential Drugs under SDL"?
The current status of this tender is "Expired". The submission deadline is 11-Feb-2026 02:00 PM. This information is sourced from official government procurement portals.
QWho issued this Assam government tender?
This tender was issued by Health and Family Welfare Department. The reference number is ESSENTIAL DRUGS UNDER SDL 7-01-2026. It is a Assam state government procurement notice.
QWhat is the estimated value of this tender?
The estimated tender value is ₹55.94 Cr. This is the approximate contract value as disclosed in the official tender document.
QWho is the lowest (L1) bidder for this tender?
Under financial bid evaluation for "Essential Drugs under SDL", ADMAC LIFESCIENCES emerged as the lowest (L1) bidder with a quoted bid amount of ₹1. Full bid rankings and vendor comparisons are available on BiharInfraTales.